Michael R. Charlton, MD, MBBS, discusses the interaction between liver disease and hepatocellular carcinoma.
Michael R. Charlton, MD, MBBS
Advertisement
Articles by Michael R. Charlton, MD, MBBS
Michael R. Charlton, MD, MBBS, discusses the effects of the COVID-19 pandemic on hepatocellular carcinoma.
Michael R. Charlton, MD, MBBS, discusses the emergence of biomarkers in hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Charlton on the Effects of the COVID-19 Pandemic on HCCApril 20th 2021
Dr. Charlton on the Emergence of Biomarkers in HCCMarch 4th 2020
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
SERENA-6 Meets PFS2 End Point With Early Switch to Camizestrant in ER+/HER2-Negative, ESR1-Mutated Advanced Breast Cancer
5